AKT1 and acute lymphoblastic leukemia: Indeed, recent evidence pointed out that B-ALL cells induced the inhibition of Akt/mTORC1 signaling and glucose metabolism that drove T-cell functional impairment, while an enforced Akt/mTORC1 signaling rescued T-cell metabolism and partially improved anti-leukemia immunity [180].